KIT, PDGFRalpha and EGFR analysis in nephroblastoma (Q42655265)

4 November 2017

KIT, PDGFRalpha and EGFR analysis in nephroblastoma (English)

1 reference

4 November 2017

7

1 reference

4 November 2017

8

1 reference

4 November 2017

13

1 reference

4 November 2017

Sylvia C Wetli

1

1 reference

4 November 2017

Ivo Leuschner

2

1 reference

4 November 2017

Dieter Harms

3

1 reference

4 November 2017

Alex Rufle

4

1 reference

4 November 2017

Anja Foerster

5

1 reference

4 November 2017

Michel Bihl

6

1 reference

4 November 2017

Michael Paulussen

9

1 reference

4 November 2017

Jakob Briner

10

1 reference

4 November 2017

Charalampos Aslanidis

11

1 reference

4 November 2017

Gerd Schmitz

12

1 reference

4 November 2017

Michael J Mihatsch

14

1 reference

4 November 2017

Inti Zlobec

15

1 reference

4 November 2017

Elisabeth Bruder

16

1 reference

4 November 2017

14 May 2008

1 reference

4 November 2017

1 reference

4 November 2017

452

1 reference

4 November 2017

637-650

1 reference

4 November 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-008-0605-x

4 November 2017

0 references

cites work

Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-008-0605-X

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-008-0605-X

The role of KIT in the management of patients with gastrointestinal stromal tumors

21 January 2018

1 reference

12 December 2020

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

1 reference

12 December 2020

An update on molecular genetics of gastrointestinal stromal tumours.

1 reference

12 December 2020

Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.

1 reference

12 December 2020

Recent advances in Wilms tumor genetics

1 reference

12 December 2020

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

1 reference

12 December 2020

Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma

1 reference

12 December 2020

Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms’ tumor

1 reference

12 December 2020

KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis

1 reference

12 December 2020

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Prognosis of Wilm's tumor in the course of the SIOP trials and studies

1 reference

12 December 2020

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

1 reference

12 December 2020

Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma

1 reference

12 December 2020

Gastrointestinal stromal tumors: imatinib and beyond

1 reference

12 December 2020

C-kit expression in pediatric solid tumors: a comparative immunohistochemical study

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

1 reference

12 December 2020

Sunitinib: from rational design to clinical efficacy

1 reference

12 December 2020

Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

KIT expression in fetal, normal adult, and neoplastic renal tissues.

1 reference

12 December 2020

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

1 reference

12 December 2020

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

12 December 2020

The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution.

1 reference

12 December 2020

Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells

1 reference

12 December 2020

Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.

1 reference

12 December 2020

Receptor tyrosine kinases and anticancer therapy

1 reference

12 December 2020

Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase inhibitors

1 reference

12 December 2020

Patterns of gene amplification in gastrointestinal stromal tumors (GIST)

1 reference

12 December 2020

Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors

1 reference

12 December 2020

Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate

1 reference

12 December 2020

Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology

1 reference

12 December 2020

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options

1 reference

12 December 2020

10.1007/S00428-008-0605-X

Identifiers

DOI

1 reference

Dimensions Publication ID

4 November 2017

0 references

1 reference